NCT02928705

Brief Summary

The purpose of this retrospective study is to analyze quality and adverse events of analgesia by telemedically supported paramedics in comparison to conventional treatment by on-scene emergency medical service (EMS) physicians in the EMS of the city of Aachen, Germany.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
381

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 10, 2016

Completed
Last Updated

October 10, 2016

Status Verified

October 1, 2016

Enrollment Period

2.2 years

First QC Date

July 28, 2016

Last Update Submit

October 6, 2016

Conditions

Keywords

analgesiaprehospitaltelemedicineambulanceopioidsteleconsultationtele-emergency medical servicesadverse eventsprehospital emergency medical service physician

Outcome Measures

Primary Outcomes (1)

  • Quality of analgesia

    Decrease of value on the Numerical Rating Scale (NRS; 0-10). The NRS is applied at initial contact with the patient and at the end of the mission.

    Time span of the respective prehospital emergency case treatment; on average a time interval of 30 - 120 minutes for each case.

Secondary Outcomes (4)

  • Rate of adverse events

    Time span of the respective prehospital emergency case treatment; on average a time interval of 30 - 120 minutes for each case.

  • Administered analgesics and their dosages

    Time span of the respective prehospital emergency case treatment; on average a time interval of 30 - 120 minutes for each case.

  • Number of patients with documented analgesia related (safety-) parameters (evaluated for each safety parameter separately)

    Time span of the respective prehospital emergency case treatment; on average a time interval of 30 - 120 minutes for each case.

  • Occurrence of nausea and vomiting

    Time span of the respective prehospital emergency case treatment; on average a time interval of 30 - 120 minutes for each case.

Study Arms (2)

telemedicine group

physician operated telemedical prehospital analgesia

Procedure: physician operated telemedical prehospital analgesia

historical control group

prehospital analgesia by on-scene EMS physicians

Procedure: prehospital analgesia by on-scene EMS physicians

Interventions

Ambulances in the EMS of the city of Aachen are equipped with a portable telemedicine system. In emergencies requiring intravenous analgesia paramedics can use this system to contact the tele-EMS physician with an audio-connection. Vital parameters (e.g., ECG, pulse oximetry, non-invasive blood pressure) can be transferred in real-time. The transmission of still pictures - taken with an official smartphone - and video streaming from the inside of the ambulance are also possible. The tele-EMS physician supports the paramedics and can delegate the application of morphine and other analgesics based on two predefined algorithms for trauma and non-trauma cases that are displayed on a context-sensitive telemedical documentation system in the teleconsultation center.

telemedicine group

This (control) group represents the conventional treatment in German emergency medical service (EMS). In addition to an ambulance manned with paramedics, a prehospital EMS physician is deployed to conduct analgesic treatment on-scene. Treatment data for this group are selected from the time period before implementing teleconsultation in routine and therefore represent a historical control group.

historical control group

Eligibility Criteria

Age1 Year+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients requiring prehospital pain treatment in the EMS of the city of Aachen

You may qualify if:

  • Initial Numerical Rating Scale ≥ 5 and
  • Documented administration of analgesics

You may not qualify if:

  • Missing consent for telemedical consultation (in teleconsultation group)
  • Initial NRS \< 5
  • Analgesia in non-ST-segment elevation acute coronary syndrome (Non-STEMI-ACS) and ST-elevating myocardial infarction (STEMI)
  • Initially unconscious patient
  • Inter-hospital transfer missions
  • Cases involving both on-scene and telemedical-EMS physicians

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Aachen

Aachen, 52074, Germany

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Rolf Rossaint, Professor, MD

    University Hospital, Aachen

    STUDY CHAIR
  • Sebastian Bergrath, MD

    University Hospital, Aachen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2016

First Posted

October 10, 2016

Study Start

January 1, 2014

Primary Completion

March 1, 2016

Study Completion

June 1, 2016

Last Updated

October 10, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

No additional research benefits.

Locations